Topical Steroids and Wound Skin Effects
Yes, topical corticosteroids cause skin thinning (atrophy) around wounds and should generally be avoided on open wounds or immediately adjacent skin, as they impair wound healing and weaken the surrounding tissue.
Mechanism of Skin Atrophy
Topical corticosteroids induce measurable skin atrophy through multiple mechanisms:
- Epidermal thinning occurs rapidly, with detectable changes in as little as 2 weeks of application, even with mild-potency steroids like hydrocortisone 1% 1
- Dermal thinning follows with prolonged use, affecting the deeper structural layers of skin 2
- The atrophic effect involves decreased keratinocyte size, reduced microvasculature, and impaired barrier function with increased transepidermal water loss 2
Risk Factors for Atrophy
The most concerning risk factors include 3:
- Higher potency steroid formulations (Class 1-2)
- Occlusion of the treated area
- Application on thinner skin areas (face, intertriginous regions, forearms)
- Older patient age
- Long-term continuous use rather than intermittent application
Impact on Wound Healing
Topical steroids directly impair wound healing 4:
- Both weak-strength (hydrocortisone 1%) and medium-strength (fluocinolone acetonide 0.025%) steroids significantly retard wound healing compared to vehicle controls
- Higher potency steroids have greater inhibitory effects on healing 4
- Moderate-dose corticosteroid treatment reduces the mechanical strength of healing wounds, with 20-day wounds showing reduced failure energies and decreased ability to withstand rupturing forces 5
Clinical Implications
For areas around wounds or surgical sites:
- Lower potency corticosteroids should be used on areas susceptible to steroid atrophy, including the forearms 3
- Avoid application directly on open wounds or immediately adjacent skin where healing is occurring
- The mechanical properties of healing wounds are impaired under corticosteroid treatment, with reduced extensibility and increased stiffness 5